Evidence map›Paper›PMID 30165520›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2018

Effects of Altering Levothyroxine Dose on Energy Expenditure and Body Composition in Subjects Treated With LT4.

Mary H Samuels, Irina Kolobova, Meike Niederhausen, Jonathan Q Purnell, Kathryn G Schuff

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Weight Gain After Thyroidectomy: A Systematic Review and Meta-Analysis.The Journal of clinical endocrinology and metabolism · 2021
    Pooled it
  4. Trial
  5. Review
  6. Article
  7. Critical Approach to Hypothyroid Patients With Persistent Symptoms.The Journal of clinical endocrinology and metabolism · 2023
    Article
  8. Serum Thyrotropin and Triiodothyronine Levels in Levothyroxine-treated Patients.The Journal of clinical endocrinology and metabolism · 2023
    Observational
  9. Article
  10. Heliyon · 2023
    Article
  11. Article
  12. Optimal Thyroid Hormone Replacement.Endocrine reviews · 2022
    Article
  13. Review
  14. Review
  15. Thyroid Hormone Action and Energy Expenditure.Journal of the Endocrine Society · 2019
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mary H SamuelsDivision of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, Oregon.
Irina KolobovaFamily and Community Medicine Residency Program, Penn State Health St. Joseph, Reading, Pennsylvania.
Meike NiederhausenBiostatistics and Design Program, OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, Oregon.
Jonathan Q PurnellKnight Cardiovascular Institute, Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, Oregon.
Kathryn G SchuffDivision of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, Oregon.
Oregon Health & Science University · USPennsylvania State University · US

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Neurocognitive and Metabolic Effects of Mild HypothyroidismR01DK075496 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI SAMUELS, MARY H · 2008 to 2012
$2.1M
Inflammatory cytokine-mediated induction of HIV cardiomyopathyK01RR024120 · NCRR · HARVARD MEDICAL SCHOOL · PI YEARLEY, JENNIFER · 2007 to 2008
$246k
NCATS NIH HHS UL1 TR002369NCRR NIH HHS K01 RR024120NIDDK NIH HHS R01 DK075496
6 · The paper itself

Abstract

Background: It is unclear whether variations in thyroid status within or near the reference range affect energy expenditure, body mass, or body composition. Methods: 138 subjects treated with levothyroxine (LT4) for hypothyroidism with normal TSH levels underwent measurement of total, resting, and physical activity energy expenditure; thermic effect of food; substrate oxidation; dietary intake; and body composition. They were assigned to receive an unchanged, higher, or lower LT4 dose in randomized, double-blind fashion, targeting one of three TSH ranges (0.34 to 2.50, 2.51 to 5.60, or 5.61 to 12.0 mU/L). The doses were adjusted every 6 weeks to achieve target TSH levels. Baseline measures were reassessed at 6 months. Results: At study end, the mean LT4 doses and TSH levels were 1.50 ± 0.07, 1.32 ± 0.07, and 0.78 ± 0.08 µg/kg (P < 0.001) and 1.85 ± 0.25, 3.93 ± 0.38, and 9.49 ± 0.80 mU/L (P < 0.001), respectively, in the three arms. No substantial metabolic differences in outcome were found among the three arms, although direct correlations were observed between decreases in thyroid status and decreases in resting energy expenditure for all subjects. The subjects could not ascertain how their LT4 dose had been adjusted but the preferred LT4 dose they perceived to be higher (P < 0.001). Conclusions: Altering LT4 doses in subjects with hypothyroidism to vary TSH levels in and near the reference range did not have major effects on energy expenditure or body composition. Subjects treated with LT4 preferred the perceived higher LT4 doses despite a lack of objective effect. Our data do not support adjusting LT4 doses in patients with hypothyroidism to achieve potential improvements in weight or body composition.

Indexed as

Body CompositionBody WeightDose-Response Relationship, DrugDouble-Blind MethodEnergy MetabolismFemaleHormone Replacement TherapyHumansHypothyroidismMaleMiddle AgedReference ValuesThyroid GlandThyroxineTreatment OutcomeThyroxine

Identifiers

PMID30165520
PMCPMC6194808
OpenAlexW2888737960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.